Evidence map›Paper›PMID 40243900›Full record

ArticleInternational journal of molecular sciences2025

Processing

Anjana Aravind, Kristina Seliverstova, Kaitlin K K Kammerlander, Thomas Henle, Eike Brunner

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Chitosan Biomaterials: Advances and Challenges-2nd Edition.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anjana AravindBioanalytische Chemie, Fakultät für Chemie und Lebensmittelchemie, TU Dresden, 01062 Dresden, Germany.ORCID 0009-0004-6641-3198
Kristina SeliverstovaLebensmittelchemie, Fakultät für Chemie und Lebensmittelchemie, TU Dresden, 01062 Dresden, Germany.
Kaitlin K K KammerlanderBioanalytische Chemie, Fakultät für Chemie und Lebensmittelchemie, TU Dresden, 01062 Dresden, Germany.
Thomas HenleLebensmittelchemie, Fakultät für Chemie und Lebensmittelchemie, TU Dresden, 01062 Dresden, Germany.
Eike BrunnerBioanalytische Chemie, Fakultät für Chemie und Lebensmittelchemie, TU Dresden, 01062 Dresden, Germany.ORCID 0000-0003-3511-9899

Funding

BMBF FENABIUM 02NUK077ADFG GRK2861 - 491865171
6 · The paper itself

Abstract

Water contamination by heavy metals, including radionuclides, is a major threat to human health and the environment. New methods for their removal are therefore needed. Adsorption is currently a common method for wastewater treatment. It depends on the physical and chemical interactions between heavy metal ions and adsorbents. The main characteristics of suitable adsorption methods are (i) a high adsorption efficiency and ability to remove different types of ions, (ii) a high retention time and cycle stability of adsorbents, and (iii) availability. Chitin is a commercially available biopolymer from marine waste that has several favourable properties: availability, low cost, high biocompatibility, biodegradability, and effective adsorption properties for metal ions. However, the processing of chitin into stable structures, such as chitin-based composites, is difficult due to its high chemical stability and extremely low solubility in most solvents. The central working hypothesis of the present work is that powdered

Indexed as

ChitinMetals, HeavyWater Pollutants, ChemicalAdsorptionWater PurificationChitinMetals, HeavyWater Pollutants, Chemicalcharacterisationcompositeeuropium adsorptionionic liquidsN-acetyl-D-glucosamineα-chitin

Identifiers

PMID40243900
PMCPMC11988694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.